Article Details

Clinical Overview: Teprotumumab for Thyroid Eye Disease - Pharmacy Times

Retrieved on: 2022-11-03 17:51:21

Tags for this article:

Click the tags to see associated articles and topics

Clinical Overview: Teprotumumab for Thyroid Eye Disease - Pharmacy Times. View article details on hiswai:

Excerpt

Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up